BioCentury
ARTICLE | Financial News

Cancer Genetics again amends IPO

February 15, 2013 1:47 AM UTC

Cancer Genetics Inc. (Rutherford, N.J.) amended its IPO and now plans to sell 5 million shares at $4-$6. A $5 price would raise $25 million and value the cancer diagnostics company at $65 million. Aeg...